Cargando…

Reporting guidelines for burden of disease studies: why and how?

BACKGROUND: The Disability Adjusted Life Year (DALY) is a frequently used metric to assess burden of disease (BoD). Many independent BoD studies have been performed across Europe, showing wide variations and inconsistencies in the application and reporting of DALY specific methods. The European Burd...

Descripción completa

Detalles Bibliográficos
Autores principales: Devleesschauwer, B, Haagsma, JA, Charalampous, P, Assunção, R, Bari, C Di, Gorasso, V, Grant, I, Hilderink, H, Idavain, J, Lesnik, T, Majdan, M, Santric-Milicevic, M, Pallari, E, Pires, SM, Plass, D, Wyper, GMA, Von der Lippe, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593658/
http://dx.doi.org/10.1093/eurpub/ckac130.097
_version_ 1784815216770416640
author Devleesschauwer, B
Haagsma, JA
Charalampous, P
Assunção, R
Bari, C Di
Gorasso, V
Grant, I
Hilderink, H
Idavain, J
Lesnik, T
Majdan, M
Santric-Milicevic, M
Pallari, E
Pires, SM
Plass, D
Wyper, GMA
Von der Lippe, E
author_facet Devleesschauwer, B
Haagsma, JA
Charalampous, P
Assunção, R
Bari, C Di
Gorasso, V
Grant, I
Hilderink, H
Idavain, J
Lesnik, T
Majdan, M
Santric-Milicevic, M
Pallari, E
Pires, SM
Plass, D
Wyper, GMA
Von der Lippe, E
author_sort Devleesschauwer, B
collection PubMed
description BACKGROUND: The Disability Adjusted Life Year (DALY) is a frequently used metric to assess burden of disease (BoD). Many independent BoD studies have been performed across Europe, showing wide variations and inconsistencies in the application and reporting of DALY specific methods. The European Burden of Disease Network (burden-eu) aims to develop guidelines for reporting DALY calculation studies which may enhance transparency and comparability of BoD estimates across Europe and beyond. METHODS: A burden-eu working group of experts generated a list of potential reporting items based on existing literature, guidance for developing guidelines and consultations with BoD experts. To pilot the drafted product, we asked BoD experts and non-experts to apply it to existing BoD studies. We received feedback and we revised the guidelines accordingly. RESULTS: The guide for DALY calculation studies comprises about 25 items that should be reported in BoD studies. We included information about the study setting, data input sources including methods for data corrections, DALY-specific methods (e.g., YLL life table, YLD approach, disability weights etc), data analyses, and data limitations. We also included information on how users can compare their new estimates with previously available BoD estimates. CONCLUSIONS: We introduced a reporting instrument for DALY calculations that can be used to document input data and methodological design choices in BoD studies. The application of such guidelines will enhance usability of BoD estimates for decision-makers as well as global, regional, and national health experts. KEY MESSAGES: Application of reporting guidelines will increase consistency and transparency in reporting of BoD studies, thus enhancing usability of BoD estimates. Reporting guidelines for BoD studies will serve as an educational tool for better understanding the complexity of DALY methodological design approaches.
format Online
Article
Text
id pubmed-9593658
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95936582022-11-22 Reporting guidelines for burden of disease studies: why and how? Devleesschauwer, B Haagsma, JA Charalampous, P Assunção, R Bari, C Di Gorasso, V Grant, I Hilderink, H Idavain, J Lesnik, T Majdan, M Santric-Milicevic, M Pallari, E Pires, SM Plass, D Wyper, GMA Von der Lippe, E Eur J Public Health Poster Walks BACKGROUND: The Disability Adjusted Life Year (DALY) is a frequently used metric to assess burden of disease (BoD). Many independent BoD studies have been performed across Europe, showing wide variations and inconsistencies in the application and reporting of DALY specific methods. The European Burden of Disease Network (burden-eu) aims to develop guidelines for reporting DALY calculation studies which may enhance transparency and comparability of BoD estimates across Europe and beyond. METHODS: A burden-eu working group of experts generated a list of potential reporting items based on existing literature, guidance for developing guidelines and consultations with BoD experts. To pilot the drafted product, we asked BoD experts and non-experts to apply it to existing BoD studies. We received feedback and we revised the guidelines accordingly. RESULTS: The guide for DALY calculation studies comprises about 25 items that should be reported in BoD studies. We included information about the study setting, data input sources including methods for data corrections, DALY-specific methods (e.g., YLL life table, YLD approach, disability weights etc), data analyses, and data limitations. We also included information on how users can compare their new estimates with previously available BoD estimates. CONCLUSIONS: We introduced a reporting instrument for DALY calculations that can be used to document input data and methodological design choices in BoD studies. The application of such guidelines will enhance usability of BoD estimates for decision-makers as well as global, regional, and national health experts. KEY MESSAGES: Application of reporting guidelines will increase consistency and transparency in reporting of BoD studies, thus enhancing usability of BoD estimates. Reporting guidelines for BoD studies will serve as an educational tool for better understanding the complexity of DALY methodological design approaches. Oxford University Press 2022-10-25 /pmc/articles/PMC9593658/ http://dx.doi.org/10.1093/eurpub/ckac130.097 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Walks
Devleesschauwer, B
Haagsma, JA
Charalampous, P
Assunção, R
Bari, C Di
Gorasso, V
Grant, I
Hilderink, H
Idavain, J
Lesnik, T
Majdan, M
Santric-Milicevic, M
Pallari, E
Pires, SM
Plass, D
Wyper, GMA
Von der Lippe, E
Reporting guidelines for burden of disease studies: why and how?
title Reporting guidelines for burden of disease studies: why and how?
title_full Reporting guidelines for burden of disease studies: why and how?
title_fullStr Reporting guidelines for burden of disease studies: why and how?
title_full_unstemmed Reporting guidelines for burden of disease studies: why and how?
title_short Reporting guidelines for burden of disease studies: why and how?
title_sort reporting guidelines for burden of disease studies: why and how?
topic Poster Walks
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593658/
http://dx.doi.org/10.1093/eurpub/ckac130.097
work_keys_str_mv AT devleesschauwerb reportingguidelinesforburdenofdiseasestudieswhyandhow
AT haagsmaja reportingguidelinesforburdenofdiseasestudieswhyandhow
AT charalampousp reportingguidelinesforburdenofdiseasestudieswhyandhow
AT assuncaor reportingguidelinesforburdenofdiseasestudieswhyandhow
AT baricdi reportingguidelinesforburdenofdiseasestudieswhyandhow
AT gorassov reportingguidelinesforburdenofdiseasestudieswhyandhow
AT granti reportingguidelinesforburdenofdiseasestudieswhyandhow
AT hilderinkh reportingguidelinesforburdenofdiseasestudieswhyandhow
AT idavainj reportingguidelinesforburdenofdiseasestudieswhyandhow
AT lesnikt reportingguidelinesforburdenofdiseasestudieswhyandhow
AT majdanm reportingguidelinesforburdenofdiseasestudieswhyandhow
AT santricmilicevicm reportingguidelinesforburdenofdiseasestudieswhyandhow
AT pallarie reportingguidelinesforburdenofdiseasestudieswhyandhow
AT piressm reportingguidelinesforburdenofdiseasestudieswhyandhow
AT plassd reportingguidelinesforburdenofdiseasestudieswhyandhow
AT wypergma reportingguidelinesforburdenofdiseasestudieswhyandhow
AT vonderlippee reportingguidelinesforburdenofdiseasestudieswhyandhow